Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
226 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
March 19, 2026
Extension Available
Until March 19, 2025
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 28, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jul 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 28, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 18, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 17, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 17, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 23, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 23, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 19, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 14, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 14, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 14, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 14, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 27, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 27, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 27, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 22, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 22, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 13, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 13, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 28, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 27, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 27, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 21, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 20, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders; none of the foregoing to include nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant
Class 042
Discovery, research and development, testing, collaboration in the nature of providing scientific research and product development in the field of pharmaceuticals, excluding all services in the field of medical tubing for infusion therapy, and also excluding all services relating to apparatus and instruments for infusing medication in the nature of infusion sets consisting of cannulae inserters, needle inserters, needle retractors, site or hub, adhesive dressing or tape, tubing, and connectors for use with insulin pumps, needles, cannulae, connectors and couplings for medical apparatus and instruments for infusing medications; none of the foregoing to include services related to nutritional supplements, personal lubricants, personal sexual lubricants, vitamin supplement patches, vitamins, or gels for use as personal lubricant
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"